Skip to main content
Canna~Fangled Abstracts

Discovery of Ring-Annulated Analogues of Cannabidiol as Potential Anticancer Agents: Synthesis and Biological Evaluation

By October 17, 2024November 22nd, 2024No Comments

. 2024 Oct 17;15(11):1832-1842.

doi: 10.1021/acsmedchemlett.4c00233. eCollection 2024 Nov 14.

Pankaj Singh Cham 1 2, Ajeet Singh 3 2, Ashiya Jamwal 3 2, Rattandeep Singh 1 2, Radhika Anand 1 2, Diksha Manhas 3 2, Sucheta Sharma 3 2, Varun Pratap Singh 1 2, Utpal Nandi 3 2, Shashank K Singh 3 2, Parvinder Pal Singh 1 2
Affiliations 

Abstract

Cannabidiol (CBD) is a nonpsychoactive cannabinoid derived from Cannabis sativa and its potential therapeutic effects extend beyond its well-known antiepileptic properties. Exploring CBD and its analogues as anticancer agents has gained significant attention in recent years. In this study, a series of novel ring-annulated analogues of CBD with oxazinyl moiety were synthesized and evaluated for their antiproliferative effect. The analogues 4d and 4h demonstrate promising activity against breast and colorectal cancer. Furthermore, mechanistic insights revealed that the identified candidates arrest the G1 phase of the cell cycle and induce apoptosis via the mitochondrial pathway in breast cancer cell lines. Notably, CBD ring-annulated analogues 4d or 4h exhibit enhanced solubility, better metabolic stability, and lowered cytochrome P450 (CYP) inhibition liability compared to CBD. These multifaceted attributes highlight the potential of cannabinoid-based candidates for further preclinical development.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

References

    1. Gould J. The cannabis crop. Nature 2015, 525 (7570), S2–S3. 10.1038/525S2a. – DOI – PubMed
    1. Owens B. Drug development: The treasure chest. Nature 2015, 525 (7570), S6–S8. 10.1038/525S6a. – DOI – PubMed
    1. Pisanti S.; Malfitano A. M.; Ciaglia E.; Lamberti A.; Ranieri R.; Cuomo G.; Abate M.; Faggiana G.; Proto M. C.; Fiore D.; Laezza C.; Bifulco M. Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacol. Ther. 2017, 175, 133–150. 10.1016/j.pharmthera.2017.02.041. – DOI – PubMed
    1. Munson A. E.; Harris L. S.; Friedman M. A.; Dewey W. L.; Carchman R. A. Antineoplastic Activity of Cannabinoids. J. Natl. Cancer Inst. 1975, 55 (3), 597–602. 10.1093/jnci/55.3.597. – DOI – PubMed
    1. Seltzer E. S.; Watters A. K.; MacKenzie D.; Granat L. M.; Zhang D. Cannabidiol (CBD) as a Promising Anti-Cancer Drug. Cancers (Basel) 2020, 12 (11), 3203.10.3390/cancers12113203. – DOI – PMC – PubMed

LinkOut – more resources

Leave a Reply